Cargando…

Influences of Intermittent Preventive Treatment and Persistent Multiclonal Plasmodium falciparum Infections on Clinical Malaria Risk

BACKGROUND: Intermittent preventive treatment (IPT) of malaria involves administration of curative doses of antimalarials at specified time points to vulnerable populations in endemic areas, regardless whether a subject is known to be infected. The effect of this new intervention on the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Liljander, Anne, Chandramohan, Daniel, Kweku, Margaret, Olsson, Daniel, Montgomery, Scott M., Greenwood, Brian, Färnert, Anna
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965101/
https://www.ncbi.nlm.nih.gov/pubmed/21048970
http://dx.doi.org/10.1371/journal.pone.0013649
_version_ 1782189470536171520
author Liljander, Anne
Chandramohan, Daniel
Kweku, Margaret
Olsson, Daniel
Montgomery, Scott M.
Greenwood, Brian
Färnert, Anna
author_facet Liljander, Anne
Chandramohan, Daniel
Kweku, Margaret
Olsson, Daniel
Montgomery, Scott M.
Greenwood, Brian
Färnert, Anna
author_sort Liljander, Anne
collection PubMed
description BACKGROUND: Intermittent preventive treatment (IPT) of malaria involves administration of curative doses of antimalarials at specified time points to vulnerable populations in endemic areas, regardless whether a subject is known to be infected. The effect of this new intervention on the development and maintenance of protective immunity needs further understanding. We have investigated how seasonal IPT affects the genetic diversity of Plasmodium falciparum infections and the risk of subsequent clinical malaria. MATERIAL AND METHODS: The study included 2227 Ghanaian children (3–59 months) who were given sulphadoxine-pyrimethamine (SP) bimonthly, artesunate plus amodiaquine (AS+AQ) monthly or bimonthly, or placebo monthly for six months spanning the malaria transmission season. Blood samples collected at three post-interventional surveys were analysed by genotyping of the polymorphic merozoite surface protein 2 gene. Malaria morbidity and anaemia was monitored during 12 months follow-up. RESULTS: Monthly IPT with AS+AQ resulted in a marked reduction in number of concurrent clones and only children parasite negative just after the intervention period developed clinical malaria during follow-up. In the placebo group, children without parasites as well as those infected with ≥2 clones had a reduced risk of subsequent malaria. The bimonthly SP or AS+AQ groups had similar number of clones as placebo after intervention; however, diversity and parasite negativity did not predict the risk of malaria. An interaction effect showed that multiclonal infections were only associated with protection in children without intermittent treatment. CONCLUSION: Molecular typing revealed effects of the intervention not detected by ordinary microscopy. Effective seasonal IPT temporarily reduced the prevalence and genetic diversity of P. falciparum infections. The reduced risk of malaria in children with multiclonal infections only seen in untreated children suggests that persistence of antigenically diverse P. falciparum infections is important for the maintenance of protective malaria immunity in high transmission settings.
format Text
id pubmed-2965101
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29651012010-11-03 Influences of Intermittent Preventive Treatment and Persistent Multiclonal Plasmodium falciparum Infections on Clinical Malaria Risk Liljander, Anne Chandramohan, Daniel Kweku, Margaret Olsson, Daniel Montgomery, Scott M. Greenwood, Brian Färnert, Anna PLoS One Research Article BACKGROUND: Intermittent preventive treatment (IPT) of malaria involves administration of curative doses of antimalarials at specified time points to vulnerable populations in endemic areas, regardless whether a subject is known to be infected. The effect of this new intervention on the development and maintenance of protective immunity needs further understanding. We have investigated how seasonal IPT affects the genetic diversity of Plasmodium falciparum infections and the risk of subsequent clinical malaria. MATERIAL AND METHODS: The study included 2227 Ghanaian children (3–59 months) who were given sulphadoxine-pyrimethamine (SP) bimonthly, artesunate plus amodiaquine (AS+AQ) monthly or bimonthly, or placebo monthly for six months spanning the malaria transmission season. Blood samples collected at three post-interventional surveys were analysed by genotyping of the polymorphic merozoite surface protein 2 gene. Malaria morbidity and anaemia was monitored during 12 months follow-up. RESULTS: Monthly IPT with AS+AQ resulted in a marked reduction in number of concurrent clones and only children parasite negative just after the intervention period developed clinical malaria during follow-up. In the placebo group, children without parasites as well as those infected with ≥2 clones had a reduced risk of subsequent malaria. The bimonthly SP or AS+AQ groups had similar number of clones as placebo after intervention; however, diversity and parasite negativity did not predict the risk of malaria. An interaction effect showed that multiclonal infections were only associated with protection in children without intermittent treatment. CONCLUSION: Molecular typing revealed effects of the intervention not detected by ordinary microscopy. Effective seasonal IPT temporarily reduced the prevalence and genetic diversity of P. falciparum infections. The reduced risk of malaria in children with multiclonal infections only seen in untreated children suggests that persistence of antigenically diverse P. falciparum infections is important for the maintenance of protective malaria immunity in high transmission settings. Public Library of Science 2010-10-27 /pmc/articles/PMC2965101/ /pubmed/21048970 http://dx.doi.org/10.1371/journal.pone.0013649 Text en Liljander et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Liljander, Anne
Chandramohan, Daniel
Kweku, Margaret
Olsson, Daniel
Montgomery, Scott M.
Greenwood, Brian
Färnert, Anna
Influences of Intermittent Preventive Treatment and Persistent Multiclonal Plasmodium falciparum Infections on Clinical Malaria Risk
title Influences of Intermittent Preventive Treatment and Persistent Multiclonal Plasmodium falciparum Infections on Clinical Malaria Risk
title_full Influences of Intermittent Preventive Treatment and Persistent Multiclonal Plasmodium falciparum Infections on Clinical Malaria Risk
title_fullStr Influences of Intermittent Preventive Treatment and Persistent Multiclonal Plasmodium falciparum Infections on Clinical Malaria Risk
title_full_unstemmed Influences of Intermittent Preventive Treatment and Persistent Multiclonal Plasmodium falciparum Infections on Clinical Malaria Risk
title_short Influences of Intermittent Preventive Treatment and Persistent Multiclonal Plasmodium falciparum Infections on Clinical Malaria Risk
title_sort influences of intermittent preventive treatment and persistent multiclonal plasmodium falciparum infections on clinical malaria risk
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965101/
https://www.ncbi.nlm.nih.gov/pubmed/21048970
http://dx.doi.org/10.1371/journal.pone.0013649
work_keys_str_mv AT liljanderanne influencesofintermittentpreventivetreatmentandpersistentmulticlonalplasmodiumfalciparuminfectionsonclinicalmalariarisk
AT chandramohandaniel influencesofintermittentpreventivetreatmentandpersistentmulticlonalplasmodiumfalciparuminfectionsonclinicalmalariarisk
AT kwekumargaret influencesofintermittentpreventivetreatmentandpersistentmulticlonalplasmodiumfalciparuminfectionsonclinicalmalariarisk
AT olssondaniel influencesofintermittentpreventivetreatmentandpersistentmulticlonalplasmodiumfalciparuminfectionsonclinicalmalariarisk
AT montgomeryscottm influencesofintermittentpreventivetreatmentandpersistentmulticlonalplasmodiumfalciparuminfectionsonclinicalmalariarisk
AT greenwoodbrian influencesofintermittentpreventivetreatmentandpersistentmulticlonalplasmodiumfalciparuminfectionsonclinicalmalariarisk
AT farnertanna influencesofintermittentpreventivetreatmentandpersistentmulticlonalplasmodiumfalciparuminfectionsonclinicalmalariarisk